Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents
Zhe Zhang, Kang Li, Guang‐Yu Zhang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 204, pp. 112604-112604
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens
Cui Deng, Heng Yan, Jun Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114888-114888
Closed Access | Times Cited: 33
The Antibacterial Activity of 1,2,3-triazole- and 1,2,4-Triazole-containing Hybrids against Staphylococcus aureus: An Updated Review (2020- Present)
Jie Li, Junwei Zhang
Current Topics in Medicinal Chemistry (2021) Vol. 22, Iss. 1, pp. 41-63
Closed Access | Times Cited: 37
Advances of bioorthogonal coupling reactions in drug development
Feiyan Zhan, Jingjie Zhu, Shaowen Xie, et al.
European Journal of Medicinal Chemistry (2023) Vol. 253, pp. 115338-115338
Closed Access | Times Cited: 13
Design and Development of Triazole Derivatives as Prospective Anticancer Agents: A Review
Harshita Sachdeva, Mohammad Saquib, Kumud Tanwar
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 19, pp. 3269-3279
Closed Access | Times Cited: 21
Design, synthesis and antibacterial activity of novel pleuromutilin derivatives with thieno[2,3-d]pyrimidine substitution
Rongcai Ding, Xiaoxia Wang, Jianfang Fu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114398-114398
Closed Access | Times Cited: 21
Click chemistry-aided drug discovery: A retrospective and prospective outlook
Rui Zhao, Junlong Zhu, Xiaoying Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116037-116037
Closed Access | Times Cited: 11
Rational utilization of 1,2,3-triazole scaffold in anti-MRSA drug development: Design strategies, structural insights and pharmacological outcomes
Atamjit Singh, Karanvir Singh, Aman Sharma, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136557-136557
Closed Access | Times Cited: 10
Design and Synthesis of Pleuromutilin Derivatives as Antibacterial Agents Using Quantitative Structure–Activity Relationship Model
Jiaming Zhang, Qinqin Liu, Haoxia Zhao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2256-2256
Open Access | Times Cited: 3
Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors
Ahmed Sabt, Eman F. Khaleel, Moataz A. Shaldam, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107703-107703
Closed Access | Times Cited: 3
Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker
Jie Liu, Guang‐Yu Zhang, Zhe Zhang, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104956-104956
Closed Access | Times Cited: 20
Recent advances in developing modified C14 side chain pleuromutilins as novel antibacterial agents
Yue Liu, Qinjiang Zhou, Yiwen Huo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116313-116313
Closed Access | Times Cited: 2
An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential
Anirudh Pratap Singh Raman, M. Aslam, Amardeep Awasthi, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit
Xiao Wang, Rui Wang, Zhaosheng Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114341-114341
Closed Access | Times Cited: 11
Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci
Nan Zhang, Di Song, Weijin Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113723-113723
Closed Access | Times Cited: 13
Design, synthesis and antibacterial evaluation of pleuromutilin derivatives
Guangxu Wu, Zihao Zhu, Jishun Li, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 59, pp. 116676-116676
Closed Access | Times Cited: 9
Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents
Fei Chai, Jun Wang, Kexin Zhou, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105859-105859
Closed Access | Times Cited: 9
Rational molecular design converting fascaplysin derivatives to potent broad-spectrum inhibitors against bacterial pathogens via targeting FtsZ
Xing Zhao, Xuanyu Cao, Hongda Qiu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116347-116347
Closed Access | Times Cited: 1
Synthesis and biological evaluation of novel 1,2,3,4-tetrahydro-β-carboline derivatives as potential antibacterial agents
Yuan‐Ze Song, Juan Zhang, Qing‐Jiang Song, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 109, pp. 129822-129822
Closed Access | Times Cited: 1
Recent advances in the synthesis of cholesterol-based triazoles and their biological applications
Anjaneyulu Bendi, Chanchal Vashisth, Sidhant Yadav, et al.
Steroids (2024) Vol. 211, pp. 109499-109499
Closed Access | Times Cited: 1
Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome
Siyu Huang, Xiao Wang, Dingyi Shen, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 38, pp. 116138-116138
Closed Access | Times Cited: 12
Design, synthesis and biological evaluation of novel indole-piperazine derivatives as antibacterial agents
Ting Liu, Xiaofang Yao, Rongrong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 89, pp. 129320-129320
Closed Access | Times Cited: 4
A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking
Zhe Zhang, Zhaosheng Zhang, Xiao Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 2087-2103
Open Access | Times Cited: 11
Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection
Han-Qing Fang, Jie Zeng, Shou‐Kai Wang, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 931-931
Open Access | Times Cited: 6
In Vitro and In Vivo Antibacterial Activity, Toxicity and Resistance Analysis of Pleuromutilin Derivative Z33 against Methicillin-Resistant Staphylococcus aureus
Yu-Han Hu, Fang Chen, Kexin Zhou, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4939-4939
Open Access | Times Cited: 6
The Very First Modification of Pleuromutilin and Lefamulin by Photoinitiated Radical Addition Reactions—Synthesis and Antibacterial Studies
Son Thai Le, Dávid Gergely Páll, Erzsébet Rőth, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2028-2028
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top